PAR-25-156-Full-Announcement.html

This is a full Funding Opportunity Announcement (FOA) for PAR-25-156, a limited competition grant opportunity titled "High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." The grant is administered by the Department of Health and Human Services' National Institutes of Health (NIH) under the National Center for Advancing Translational Sciences program (CFDA 93.350).

The RC2 grant mechanism targets existing UM1 Clinical and Translational Science Awards (CTSA) Program Hubs to develop and demonstrate unique capabilities, research platforms, and resources that address critical gaps in clinical and translational science. Limited to public higher education institutions, this opportunity aims to establish foundational programs that can potentially be adopted by additional CTSA Program Hubs in the future. The focus is on innovative solutions that can overcome current roadblocks in clinical and translational research, with clinical trials being optional under this announcement.